CONVALO HEALTH INTERNATIONAL CORP (CVE:CXV) Upgrades Senior Management

0
1054

CONVALO HEALTH INTERNATIONAL CORP (CVE:CXV) a leading entity in the United States addiction recovery marketplace updated that it has restructured its Board and enhanced senior management team.

The changes

Effective immediately, Chris Heath has been promoted to CEO and has been selected to Convalo board. Edward John Allera will act as Chairman of the Board. David Costine will take the role of a non-Executive Director, retiring as an administrator and decision maker for the firm. Several other consultants and senior executives have terminated their services at the demand of the new management team.

Mr. Allera reported that he is delighted to commence the new fiscal year with fresh leadership. Both he and Heath are focused on improving operations quickly. They believe their new team can get Convalo back to the rapid growth business. At the same time, Heath reported that he is grateful for this opportunity to get fresh energy to Convalo.

He is in a position to infuse changes and refocus operations on profit generation and revenue growth and he intends to do that quickly. Heath is closing a strategic assessment of the business and intend to share that along with other improvements made, with the company’s shareholders shortly.

Heath further added that he has honed his team in the previous few weeks and lowered corporate overhead in this process. He wants to thank the last team for getting them to where they stand today and bid them luck in their upcoming undertakings.

As part of the recent management change, Convalo anticipates more options will be open in the employee option pool as some options will expire in the coming 90 days as they were issued to consultants and employees who are no longer associated with the firm and the options are well out of the funds. The firm’s board released 500,000 options to Heath with a strike rate at $0.085.

This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.